Alexander F. Lipka

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Lambert-Eaton myasthenic syndrome.

Lambert-Eaton myasthenic syndrome.

Journal: Handbook of clinical neurology

Published: March 17, 2024

Enrichment of serum IgG4 in MuSK myasthenia gravis patients.

Enrichment of serum IgG4 in MuSK myasthenia gravis patients.

Journal: Journal of neuroimmunology

Published: August 20, 2022

Accuracy of patient-reported data for an online patient registry of autoimmune myasthenia gravis and Lambert-Eaton myasthenic syndrome.

Accuracy of patient-reported data for an online patient registry of autoimmune myasthenia gravis and Lambert-Eaton myasthenic syndrome.

Journal: Neuromuscular disorders : NMD

Published: July 22, 2020

Lung cancer prediction in Lambert-Eaton myasthenic syndrome in a prospective cohort.

Lung cancer prediction in Lambert-Eaton myasthenic syndrome in a prospective cohort.

Journal: Scientific reports

Published: January 09, 2020

Lowering the cutoff value for increment increases the sensitivity for the diagnosis of Lambert-Eaton myasthenic syndrome.

Lowering the cutoff value for increment increases the sensitivity for the diagnosis of Lambert-Eaton myasthenic syndrome.

Journal: Muscle & nerve

Published: November 08, 2019

Long-term follow-up, quality of life, and survival of patients with Lambert-Eaton myasthenic syndrome.

Long-term follow-up, quality of life, and survival of patients with Lambert-Eaton myasthenic syndrome.

Journal: Neurology

Published: April 28, 2019

The possibility of obtaining marketing authorization of orphan pharmaceutical compounding preparations: 3,4-DAP for Lambert-Eaton Myasthenic Syndrome.

The possibility of obtaining marketing authorization of orphan pharmaceutical compounding preparations: 3,4-DAP for Lambert-Eaton Myasthenic Syndrome.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: October 05, 2017

Aggregated N-of-1 trials for unlicensed medicines for small populations: an assessment of a trial with ephedrine for myasthenia gravis.

Aggregated N-of-1 trials for unlicensed medicines for small populations: an assessment of a trial with ephedrine for myasthenia gravis.

Journal: Orphanet journal of rare diseases

Published: February 09, 2017

Ephedrine treatment for autoimmune myasthenia gravis.

Ephedrine treatment for autoimmune myasthenia gravis.

Journal: Neuromuscular disorders : NMD

Published: September 06, 2016

Activity limitations in myasthenia gravis and relation to clinical variables.

Activity limitations in myasthenia gravis and relation to clinical variables.

Journal: Muscle & nerve

Published: June 13, 2016

Prevalence and clinical aspects of immigrants with myasthenia gravis in northern Europe.

Prevalence and clinical aspects of immigrants with myasthenia gravis in northern Europe.

Journal: Muscle & nerve

Published: April 19, 2016

Ephedrine as add-on therapy for patients with myasthenia gravis: protocol for a series of randomised, placebo-controlled n-of-1 trials.

Ephedrine as add-on therapy for patients with myasthenia gravis: protocol for a series of randomised, placebo-controlled n-of-1 trials.

Journal: BMJ open

Published: July 18, 2015

Showing 1-12 of 19

Last Updated: 09/26/2026